Market Access News | pharmaphorum

News

Alfasigma claims early FDA nod for ex-GSK liver drug

Alfasigma has claimed the first approval, in the US, for linerixibat, a drug for liver disease PBC licensed from GSK for $690m a few days ago.

News

J&J gets FDA okay for psoriasis drug icotrokinra

Johnson & Johnson's much-anticipated oral IL-23 drug, icotrokinra, has claimed FDA approval as Icotyde for first-line treatment of plaque psoriasis.

News

First MHRA/NICE aligned guidance due in June

The aligned regulatory pathway for UK drugs regulator MHRA and reimbursement authority NICE gets underway on 1st April.

News

US judge rules Kennedy's vaccine changes 'unlawful'

A US judge has stymied attempts by HHS Secretary Kennedy to change immunisation policy, stopping this week's vaccine advisory panel from going ahead.

News

AZ piles pressure on MSD et al in gastric cancer

AstraZeneca's cancer immunotherapy Imfinzi has been approved in the EU for use before and after surgery for early-stage gastric cancer.

News

GSK's RSV shot cleared in US for all adults

GSK is back on level pegging with its rivals in the RSV vaccine category in the US, after getting FDA approval for Arexvy in the 18 to 49 age bracket.

Alfasigma claims early FDA nod for ex-GSK liver drug

J&J gets FDA okay for psoriasis drug icotrokinra

First MHRA/NICE aligned guidance due in June

US judge rules Kennedy's vaccine changes 'unlawful'

AZ piles pressure on MSD et al in gastric cancer

GSK's RSV shot cleared in US for all adults

AI specialist Chai Discovery raises $400m

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks